Back to search
FDAFDA · Food and drugs·Recall number D-0789-2017

Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

Published May 24, 2017 · Recall initiated: May 15, 2017

Summary

FDA records drug Class II recall D-0789-2017, published May 24, 2017 and initiated May 15, 2017. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 90,450 bags; Lot: Lot #: P342485, Exp 11/30/17; P344408, Exp 12/31/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: customer complaints received for the presence of leaks.

What to do

Voluntary: Firm initiated

Get an email if MILRINONE LACTATE IN DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MILRINONE LACTATE IN DEXTROSE
Manufacturer
Baxter Healthcare Corporation
Distributor
US and foreign countries: United Arab Emirates, Colombia, and Canada
Lot
Lot #: P342485, Exp 11/30/17; P344408, Exp 12/31/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48 recalled?

Yes. FDA published recall D-0789-2017 on May 24, 2017. Reported hazard: Lack of assurance of sterility: customer complaints received for the presence of leaks.

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MILRINONE LACTATE IN DEXTROSE.